The two common targets for the treatment of AD by the 6 drugs are Mitogen-Activated Protein Kinase 14 (MAPK14) and Mitogen-Activated Protein Kinase 10 (MAPK10), with specific information provided in Table 3. Here, MAPK14 is linked to Alzheimer disease.